- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about EXEL
Recent news which mentions EXEL
5 Value Stocks That Can Make You Richer in 2022
January 20, 2022
From Motley Fool
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022
January 14, 2022
From Motley Fool
From Benzinga
7 of the Best Cheap Stocks Under $20 for 2022 to Buy Now
January 03, 2022
From InvestorPlace
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
From Benzinga
2 Growth Stocks Analysts Think Can Double Within 2 Years
December 15, 2021
From Motley Fool
Got $1,000? These 3 Stocks Could Be Bargain Buys for 2022 and Beyond
December 10, 2021
From Motley Fool
The Smartest Stocks to Buy With $200 in December
December 10, 2021
From Motley Fool
The Smartest Stocks to Buy With $20 Right Now
November 12, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy in November
November 04, 2021
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 03, 2021
From Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
Exelixis, inc (EXEL) Q3 2021 Earnings Call Transcript
November 02, 2021
Tickers
EXEL
From Motley Fool
SAVA Stock: 8 Things to Know as Cassava Sciences Rockets Higher
November 02, 2021
From InvestorPlace
Exelixis Earnings Perspective: Return On Capital Employed
November 02, 2021
Tickers
EXEL
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
2 Growth Stocks That Could Deliver 1,000% Returns
October 31, 2021
From Motley Fool
3 Biotech Stocks That Could Make You Richer
October 30, 2021
From Motley Fool
Down 76%: Is Cortexyme Stock a Bargain?
October 28, 2021
From Motley Fool
4 Growth Stocks With 187% to 434% Upside, According to Wall Street
October 13, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
From Benzinga
Got $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter
September 28, 2021
From Motley Fool
Exelixis's Cabometyx Scores FDA Nod In Differentiated Thyroid Cancer; ESMO Presentation
September 20, 2021
Tickers
EXEL
From Benzinga
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 2%
September 20, 2021
From Benzinga
Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery
September 16, 2021
From Benzinga
2 Top Biotech Stocks to Buy Right Now
September 11, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.